Desenvolvimento e avaliação de software para acompanhamento de gestantes com sífilis

Abstract

Gestational syphilis is a worldwide problem and can be controlled through effective public health actions and measures. The objective of this study was to develop and evaluate a mobile application (app) in order to facilitate the monitoring of pregnant women with syphilis during the prenatal period until the postpartum period. This is a technological production aimed at building a mobile application. The Gestisífilis app allows you to obtain treatment data for the pregnant woman, including data regarding the tests performed, clinical stage of the disease, therapeutic scheme, VDRL examination tracking during the 9 gestational months, through the generation of reports that can be accessed and sent via email. The data entered is password protected by the system administrator, safeguarding patients' privacy. The app was installed on 23 smartphones with the Android system, from different nurses, to assess the compatibility of the system, and to evaluate the functionality of the app. The user's profile and degree of satisfaction were assessed using a QUIS questionnaire (Questionnaire for User Interaction Satisfaction), which was applied by the Google Form platform. The downloads on different smartphones showed that the synchronization and sending of the app's data works correctly. The results of the questionnaire showed that the majority of the evaluators were women (82.6%), under the age of 30 years (47.8%), with a specialist title (87%) professional experience between 1-2 years ( 52%). Regarding the usability of the app, the results showed that there was no statistically significant difference between professionals with up to 2 years and more than 2 years of experience (p 0.05), with average and median scores very close to the maximum value (10) . We concluded that the Gestisífilis app showed efficiency in the reception and transmission of information and approval of usability by the evaluators and can be a great tool in the monitoring of pregnant women with syphilis.